Axios @axios
Amgen has agreed to buy rare disease drugmaker Horizon Therapeutics for $27.8 billion in cash, making the acquisition the largest pharma merger of the year. https://t.co/qS6aNWdpgG — PolitiTweet.org
Created
Mon Dec 12 17:00:36 +0000 2022
Likes
12
Retweets
2
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely Available
Axios @axios
Amgen has agreed to buy rare disease drugmaker Horizon Therapeutics for $27.8 billion in cash, making the acquisition the largest pharma merger of the year. https://t.co/qS6aNWdpgG — PolitiTweet.org